close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardlytics, Inc. - Common Stock (NQ:CDLX)

1.940 +0.040 (+2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardlytics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Cardlytics, Inc.
Via Business Wire
Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release
From Cardlytics, Inc.
Via Business Wire
Law Offices of Howard G. Smith Encourages Cardlytics, Inc. (CDLX) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cardlytics, Novo Nordisk, Micron, and ModivCare and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Cardlytics, Inc. (NASDAQ: CDLX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
From DiCello Levitt LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Block, and Crocs and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Cardlytics, Inc. Shareholders with Large Losses Should Contact Robbins LLP for Information About the CDLX Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cardlytics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cardlytics, Novo Nordisk, Micron, and ModivCare and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
Cardlytics, Inc. Stock Alert: Robbins LLP Reminds Investors of the Class Action Against CDLX
From Robbins LLP
Via GlobeNewswire
CARDLYTICS, INC. (NASDAQ: CDLX) INVESTOR ALERT: Investors With Large Losses in Cardlytics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi LLP
Via GlobeNewswire
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cardlytics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
From Faruqi & Faruqi, LLP
Via Business Wire
Cardlytics, Inc. Announcement: If You Have Suffered Losses in Cardlytics, Inc. (NASDAQ: CDLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
CDLX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Cardlytics, Inc. Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Securities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Securities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Cardlytics, Inc. (CDLX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Encourages Cardlytics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – CDLX
From Rosen Law Firm
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today